SIDO - PT. Industri Jamu dan Farmasi Sido Muncul Tbk

Rp 915

0 (0%)

JAKARTA – PT Industri Jamu dan Farmasi Sido Muncul Tbk (SIDO) collected IDR 2.77 trillion in sales in the third quarter of 2021. It was slightly higher than the gain reported in the same period last year of IDR 2.25 trillion. Along with this gain, its current year’s profit also proliferated to IDR 865.49 billion from IDR 640.80 billion.

In the Financial Report of Q3 2021 published earlier today (18/10), David Hidayat, President Director of Sido Muncul, revealed that the most extensive contributor is the herbal medicine and supplement sales of IDR 1.76 trillion. Food and beverages sales followed closely with IDR 899.30 billion, while pharmaceutical products sales brought in IDR 109.04 billion. “Up until now, the COVID-19 does not significantly affect our operational activities,” he added.

In the same period last year, herbal medicine and supplement sales generated IDR 1.44 trillion, while food and beverages contributed IDR 711.18 billion. Pharmaceutical products also came last with IDR 92.83 billion worth of contribution.

By the end of Q3 2021, SIDO’s gross and operating profit reached IDR 1.56 trillion and IDR 1.07 trillion. Both of these were elevated from the initial IDR 1.21 trillion and IDR 786.04 billion reported in Q3 2020. (LK/ZH)